跳至主要内容
临床试验/CTIS2024-513041-37-00
CTIS2024-513041-37-00进行中(未招募)1 期

CeRebrUm and CardIac protection with ALlopurinol in Neonates with Critical Congenital Heart Disease requiring Cardiac Surgery with Cardiopulmonary Bypass - 18-791

niversitair Medisch Centrum Utrecht0 个研究点目标入组 236 人开始时间: 2024年7月8日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
236

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 至 17(—)
性别
All

入选标准

  • Neonates with a prenatally (before birth) or postnatally (after birth) confirmed diagnosis of critical congenital heart disease requiring neonatal cardiac surgery with cardiopulmonary bypass within the first 4 weeks of life

排除标准

  • Inability to enroll the patient before the start of delivery, in case of prenatal diagnosis or 24h before surgery in case op postnatal diagnosis., Doubt whether the aortic arch anomaly before birth requires cardiac surgery with CPB in the neonatal period., Gestational age below 36 weeks and /or birth weight less than 2000 gram., Patient considered moribund., Decision for comfort care only, Surgery not requiring cardiopulmonary bypass.

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验